Helmerich and Payne Inc

HP is holding its Stage 2 uptrend with price pulling back into the rising short-term EMAs near prior horizontal resistance turned support. The healthy retracement into the 9-/21-day EMA zone offers a high-probability entry for continuation participation. Execution is justified now, provided the 9-day EMA holds as support.

• ↑Q2 FY26 revenue $14.4 B (+9% YoY); non-GAAP EPS $0.86 (+21%)
• ↑OpenAI partnership to integrate AI, targeting ~$1 B in run-rate savings by FY28
• ↓Goldman Sachs “Sell” warns of ongoing margin pressure in PCs